Literature DB >> 15292342

Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes.

Helen C Looker1, Jonathan Krakoff, Tohru Funahashi, Yuji Matsuzawa, Sachiyo Tanaka, Robert G Nelson, William C Knowler, Robert S Lindsay, Robert L Hanson.   

Abstract

Adiponectin is produced exclusively by adipocytes, and its serum concentration is inversely associated with adiposity. This study examines the relationship among diabetes, renal function, and serum adiponectin in Pima Indians. Serum adiponectin was measured in 1069 people in whom glycemia and renal function had been measured. Serum adiponectin, adjusted for age, sex, and body mass index, was lowest in those with impaired glucose regulation or diabetes of less than 10 yr duration and highest in those with normal glucose tolerance or diabetes of duration of at least 10 yr. Both urinary albumin to creatinine ratio (ACR) and serum creatinine were positively correlated with adiponectin (Spearman's r = 0.43; P < 0.0001, and r = 0.37; P < 0.0001, respectively) in diabetic subjects. After stratification by albuminuria (normoalbuminuria ACR < 30 mg/g, microalbuminuria ACR = 30-299 mg/g, and macroalbuminuria ACR >or= 300 mg/g), the highest adiponectin concentration was in the macroalbuminuria group (geometric mean = 9.6 microg/ml) and the lowest was in the normoalbuminuric group (geometric mean = 5.6 microg/ml). After adjustment for age, sex, body mass index, and diabetes duration, the serum adiponectin concentration in the macroalbuminuria group was significantly higher than in both other groups (P < 0.0001). Serum adiponectin is lowest in the presence of impaired glucose regulation and early diabetes. In the presence of diabetes, serum adiponectin is positively associated with abnormal renal function and diabetes duration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292342     DOI: 10.1210/jc.2003-031916

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

Review 1.  The use of targeted biomarkers for chronic kidney disease.

Authors:  Prasad Devarajan
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

2.  Relationship between ADIPOQ gene, circulating high molecular weight adiponectin and albuminuria in individuals with normal kidney function: evidence from a family-based study.

Authors:  C Menzaghi; S De Cosmo; M Copetti; L Salvemini; C De Bonis; D Mangiacotti; G Fini; F Pellegrini; V Trischitta
Journal:  Diabetologia       Date:  2011-01-13       Impact factor: 10.122

3.  Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications.

Authors:  J Frystyk; L Tarnow; T Krarup Hansen; H-H Parving; A Flyvbjerg
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

Review 4.  Sex, diabetes and the kidney.

Authors:  Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

Review 5.  Role of adipocytokines in predicting the development of diabetes and its late complications.

Authors:  Nese Ersoz Gulcelik; Aydan Usman; Alper Gürlek
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

6.  Adiponectin gene polymorphisms in Egyptian type 2 diabetes mellitus patients with and without diabetic nephropathy.

Authors:  Amal S El-Shal; Haidy E Zidan; Nearmeen M Rashad
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

7.  Relationships between plasma adiponectin and body fat distribution, insulin sensitivity, and plasma lipoproteins in Alaskan Yup'ik Eskimos: the Center for Alaska Native Health Research study.

Authors:  Anna V Goropashnaya; Johanna Herron; Mary Sexton; Peter J Havel; Kimber L Stanhope; Rosemarie Plaetke; Gerald V Mohatt; Bert B Boyer
Journal:  Metabolism       Date:  2009-01       Impact factor: 8.694

8.  The diagnostic value of adiponectin multimers in healthy men undergoing screening for prostate cancer.

Authors:  Edward A Medina; Xiaoyu Shi; Marcia H Grayson; Donna P Ankerst; Carolina B Livi; Maria V Medina; Ian M Thompson; Robin J Leach
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-02       Impact factor: 4.254

9.  Decorin deficiency enhances progressive nephropathy in diabetic mice.

Authors:  Kevin Jon Williams; Gang Qiu; Hitomi Katoaka Usui; Stephen R Dunn; Peter McCue; Erwin Bottinger; Renato V Iozzo; Kumar Sharma
Journal:  Am J Pathol       Date:  2007-09-20       Impact factor: 4.307

10.  Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.

Authors:  Maximilian von Eynatten; Dan Liu; Cornelia Hock; Dimitrios Oikonomou; Marcus Baumann; Bruno Allolio; Grigorios Korosoglou; Michael Morcos; Valentina Campean; Kerstin Amann; Jens Lutz; Uwe Heemann; Peter P Nawroth; Angelika Bierhaus; Per M Humpert
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.